This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Trade secret guardrails toughened in EU’s agreement on crisis licensing bill

By Inbar Preiss ( May 22, 2025, 11:13 GMT | Insight) -- EU lawmakers and member states have reached a political agreement on new compulsory licensing rules for crisis situations, toughening protections for trade secrets after months of negotiations. The final text is a win for pharmaceutical companies like Pfizer and Moderna, explicitly excluding obligations to disclose proprietary know-how, even during emergencies. The draft legislation still needs final approval before it can pass into law.EU lawmakers and member states reached a political agreement late on Wednesday on compulsory licensing rules for health crises. The final legislative text toughens protections around trade secrets — finalizing one of the most divisive issues in the months-long negotiations....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login